Altogether, this work suggests that a compromised Mdm2 destruction pathway might lead to subsequent Mdm2 stabilization, thus enhancing Mdm2 oncogenic activity by promoting p53 destruction and facilitating tumor progression. The gene discussed is MDM2; the disease is neoplasm.